Look-alike tubes kill patients regularly: Why is this still allowed?
Filed under: Ethics, Health care/Treatment trends, Healthcare Legal & Compliance, Healthcare Technology News, In this week's e-newsletter, Latest News & Views
Mistakes as simple — and avoidable — as confusing an IV with a feeding tube regularly injure and kill patients. And industry interests seem content to allow it to continue. Read more
Unlicensed ‘doc’ accused of $1m stem cell scam
Filed under: Ethics, Fraud & Waste, Healthcare Legal & Compliance, In this week's e-newsletter, Latest News & Views
Alfred Sapse faces 20 charges of wire and mail fraud for allegedly scamming 134 patients. Read more
New test for Alzheimer’s may be on the way
Filed under: Health care/Treatment trends, Healthcare Technology News, In this week's e-newsletter, Latest News & Views, Patient/Client Communication
A new type of brain scan could give doctors their first chance to prove Alzheimer’s diagnoses while patients are alive. Read more
FDA blasts quality control at McNeil plant
Filed under: Fraud & Waste, Health care/Treatment trends, Healthcare Finance, Healthcare Legal & Compliance, In this week's e-newsletter, Latest News & Views
More than 20 different problems with manufacturing and quality control processes at a major pharmaceutical plant were outlined in a report just released by the FDA. Read more
The other side of health reform: Increased wellness initiatives
Filed under: Health care/Treatment trends, Healthcare Reform News, In this week's e-newsletter, Insurance, Latest News & Views, Medicare & Medicaid News
Largely unnoticed in the run-up to the recent passage of the health reform law, President Obama also has his sights on improving programs focused on disease prevention and general wellness. Read more
80% of nitroglycerin scripts are filled with ‘unapproved’ pills
Filed under: Health care/Treatment trends, Healthcare Legal & Compliance, In this week's e-newsletter, Latest News & Views, Patient/Client Communication
Several million cardiac patients have been taking pills never approved, or tested for safety, by the FDA. Read more
Senate report raises questions about FDA after-market review
Filed under: Ethics, Health care/Treatment trends, In this week's e-newsletter, Latest News & Views
A new report from the Senate Finance Committee highlights a potential conflict of interest within the FDA — and the safety of one of the world’s top-selling medications. Read more
Generics may not be as effective as we thought
Filed under: Health care/Treatment trends, In this week's e-newsletter, Latest News & Views, Patient/Client Communication
The more research that’s done, the more some physicians worry that generic meds do work differently than the brand names they copy. Read more
Study: Docs confused about certain med uses
Filed under: Health care/Treatment trends, In this week's e-newsletter, Latest News & Views
Turns out, doctors aren’t as up-to-date as they think they are on off-label uses of prescriptions — which could lead them to order treatments they wouldn’t otherwise. Read more
FDA looks to regulate Web marketing of medical products
Filed under: Communication, Ethics, Healthcare Legal & Compliance, Healthcare Technology News, In this week's e-newsletter, Latest News & Views
We may soon have clearer guidelines as to what medical vendors can say when promoting their products via new social media outlets. Read more
